PRQR
ProQR Therapeutics N.V.stockNASDAQ
At CloseNov 18, 2026 3:59:57 PM EST
1.08USD-6.087%(-0.07)881,588
Pre-marketNov 18, 2026 9:27:30 AM EST
1.15USD0.000%(0.00)
After-hoursNov 18, 2026 4:00:30 PM EST
1.10USD+1.852%(+0.02)
Loading…
Loading…
154.05M
Healthcare
Biotechnology
CEO
Daniel De Boer
HQ
Leiden, Zuid Holland, Netherlands
130
Previous Close
$1.15
Beta
1.88
52-Week High
$2.49 2025-12-16
52-Week Low
$1.07 2026-11-18
SMA 50
$1.52
SMA 200
$1.67
Avg. Vol 10D
630,189
Avg. Vol 30D
864,937
Avg. Vol 90D
815,539
Relative Vol
1.02
141.33M
91.44M
64.70%
2,888,655
3.16%
2.93
52%/48%
50.09%
40.56%
0.4100%
1,800,000
489
4,606
10,723
24.0M
-50.5M
-60.1M
-216.64
-69.42
Nov 12, 2026
ProQR Therapeutics Q3 Sales Increase ·
RTTNews
ProQR GAAP EPS of -€0.09, revenue of €5.16M ·
Seeking Alpha
Oct 28, 2026
Sep 30, 2026
Sep 23, 2026
PRQR Profile
proqr therapeutics is a leiden, nl based biotech company focused on developments of drugs to treat genetic disorders. based on a novel proprietary technology we discover and develop drugs to change the lives of patients around the world. founded by industry icons and based on ground breaking science we strive to make a meaningful impact. check out our website for vacancies: www.proqr.com
PRQR Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 1.36 | 2026-11-12 | -19.85% | 9.659 |
| 1M | 1.31 | 2026-10-19 | -16.79% | 1.962 |
| 3M | 2.22 | 2026-08-19 | -50.90% | 1.786 |
| 6M | 1.43 | 2026-05-19 | -23.78% | 1.833 |
| 1Y | 2.03 | 2025-11-19 | -46.30% | 1.883 |
| 2Y | 3.60 | 2024-11-19 | -69.72% | — |
| 5Y | 7.77 | 2021-11-19 | -85.97% | 1.120 |
PRQR Stock Summary
ProQR Therapeutics N.V. (NASDAQ:PRQR) stock price today is $1.09, and today's volume is 881,588. PRQR is down 5.217% today. The 30 day average volume is 864,937. PRQR market cap is $154.05M with 141.33M shares outstanding.
